Examples were electrophoresed through a pH gradient made by an ampholytic option (Pharmalyte carrier ampholytes, GE, CAS #70852-56-1) until they reached a pH add up to their pI
Examples were electrophoresed through a pH gradient made by an ampholytic option (Pharmalyte carrier ampholytes, GE, CAS #70852-56-1) until they reached a pH add up to their pI. been shown to be comparable between BAT1706 and European union/US-bevacizumab also, with statistical equivalence proven for VEGF-A binding and neutralizing activity. Summary Overall, this extensive comparability exercise…